Medication & Safety
Return and Refund Policy: What to Check Before You Buy
A clear return and refund policy tells you a lot about a seller before anything goes wrong. Here is what to check before...
Search for retatrutide and you will find sellers within seconds. Vials, prices, dosing charts, delivery to Pakistan. It looks like a market for a real medicine.
It is not. Retatrutide is not approved in any country on earth. No legitimate manufacturer sells it to the public. Whatever those vials contain, it did not come through a regulated supply chain, because no such chain exists for that drug.
This article explains what these products actually are and what the evidence says about the risk.
The scale of the problem
The World Health Organization estimates that at least 1 in 10 medical products in low- and middle-income countries is substandard or falsified.
That figure applies to medicines moving through ordinary channels, including pharmacies. It is not a statistic about the unregulated online market, where the proportion is inevitably far worse.
WHO defines two categories that matter here. Substandard products fail quality specifications, usually through poor manufacturing or inadequate quality control. Falsified products deliberately misrepresent their identity, composition or source, made to deceive for financial gain.
WHO also notes specifically that these products are often sold online or in informal markets, and that countries spend an estimated 30.5 billion dollars a year on them.
Pakistan sits squarely in the affected category.
What "research use only" actually means
Almost every peptide seller carries some version of this label. "For research purposes only. Not for human consumption."
People read it as a formality, a wink between seller and buyer. It is not. It is a functioning legal shield, and understanding what it does clarifies the whole transaction.
By labelling a product for research, the seller sidesteps pharmaceutical regulation entirely. Research chemicals do not require approval for human use, do not require pharmaceutical-grade manufacturing, do not require sterility testing for injection, do not require accurate dose labelling, and do not require any pharmacovigilance system.
Every one of those protections exists because their absence historically harmed people.
The label also transfers liability completely. If the vial contains the wrong substance, the wrong concentration, or bacterial contamination, and you injected it, you did so against the stated instructions. There is no recourse. That is the entire purpose of the wording.
What can actually be in the vial
Testing of unregulated peptide products across various markets has found a consistent range of problems.
Nothing active. The most common outcome. Sterile water, saline, or inert powder. You lose money and time.
Wrong concentration. Labelled 10 mg, containing 3 mg or 30 mg. Underdosing wastes the course. Overdosing on a GLP-1 drug produces severe, prolonged vomiting and dehydration.
A different drug entirely. Substituting a cheaper peptide, or in the worst documented cases, insulin. Injecting insulin when you do not need it can cause life-threatening hypoglycaemia.
Bacterial contamination. This is the risk people underestimate most. Injectable products require sterile manufacturing. A non-sterile injectable can cause abscesses, cellulitis and bloodstream infection.
Degraded product. Peptides are fragile and temperature-sensitive. A vial that sat in a shipping container in Karachi heat may have lost most of its activity regardless of how it started.
You cannot detect any of this by looking. Packaging, holograms and batch numbers are all straightforward to copy convincingly.
The reconstitution problem
Most research peptides arrive as a freeze-dried powder that you mix yourself with bacteriostatic water.
This means you are performing a sterile pharmaceutical preparation step, in your kitchen, without training, without a laminar flow hood, and without any way to verify the result.
You then calculate your own dose. Peptide dosing involves converting between milligrams, units on an insulin syringe, and concentration after reconstitution. Arithmetic errors here are common and consequential. A tenfold error is entirely possible and produces exactly what you would expect.
Regulated medicines arrive pre-filled and pre-dosed for precisely this reason.
Why the approved drugs get counterfeited too
The problem is not limited to unapproved compounds.
Semaglutide and tirzepatide have both faced sustained global supply shortages driven by weight loss demand. Wherever legal supply cannot meet demand, counterfeit supply appears to fill the gap.
Falsified semaglutide pens have been identified in multiple countries. Some contained insulin. Some contained nothing.
In Pakistan, where neither drug is registered and everything arrives through import or informal channels, there is no regulatory checkpoint at all between an unknown source and your arm.
The questions worth asking
If you are considering buying any injectable weight loss product from a non-registered source, these questions clarify things quickly.
- Is this drug approved for human use anywhere? For retatrutide, survodutide and cagrilintide, the answer is currently no.
- Can the seller show a verifiable import trail from the actual manufacturer?
- Was the cold chain maintained through every stage of transit?
- Who reviewed whether this drug is medically appropriate for me?
- What happens if it harms me? Who is accountable?
If the answers are unclear, the product is unverified regardless of how professional the website looks or how many testimonials appear beneath it.
The medical supervision gap
There is a risk here beyond product quality, and it gets far less attention.
GLP-1 medications have real contraindications. A personal or family history of medullary thyroid carcinoma. Multiple endocrine neoplasia type 2. Previous pancreatitis. Pregnancy. Interactions with insulin and sulfonylureas that require dose adjustment.
Someone buying online is screened for none of this. Nobody checks their history, nobody adjusts their other medications, and nobody is monitoring for pancreatitis or gallbladder disease.
The drug being genuine would not fix that. It is a separate failure.
This is the difference a regulated route provides. GLP-1 support reviewed by a doctor before it ships means a physician assesses your history against known contraindications before anything is dispatched. METASLIM™ is a physician-reviewed sublingual supplement rather than a pharmaceutical peptide, so it is a different category of product entirely and its results should not be compared with injectable trial figures. What it does provide is consistent quality and clinical screening, which an unverified vial from an online seller cannot.
Our page on why physician oversight matters covers what that review involves. The complete GLP-1 medication list sets out what is genuinely approved, and retatrutide explains why the most-marketed peptide is also the least available.
The summary
Peptides sold online for weight loss are unregulated products. "Research use only" is a legal shield, not a quality claim.
WHO puts substandard or falsified medicines at 1 in 10 across low- and middle-income countries through normal channels. The unregulated online market is worse by definition.
The risks are wrong contents, wrong concentration, contamination, degradation, self-reconstitution errors, and no medical screening whatsoever.
Drugs that are not approved anywhere cannot be bought legitimately anywhere. If someone is selling you retatrutide today, that fact alone tells you what you need to know.
Get started with a physician review rather than an unverified vial.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.